It accounts for 2-4% of the cancers diagnosed annually in the United States. The risk factors for developing oral cancer include tobacco consumption in any form (chewing or smoking), heavy alcohol consumption, a spicy food diet, recurrent trauma to the mouth due to a broken tooth or ill-fitting dentures, human papillomavirus infection, etc.
Diagnosing cancers at an early stage is crucial to improving the survival rate and reducing the treatment expenses.
How do you screen for oral cancer?
Early detection of oral cancer by visual inspection of the mouth is proposed in the countries with high incidence. The ENT (ear, nose, and throat) surgeon or the dental surgeon may call the person for a routine check-up to examine the oral cavity for any abnormal white or red patches or mass. The various methods to distinguish cancerous lesions from the normal mucosa include the use of toluidine blue dye, brush biopsy, chemiluminescence, and tissue autofluorescence.
Types of oral cancers that involve the squamous cell present with visible changes in the oral mucosa. These may look like white patches (leukoplakia), red patches (erythroplakia), purple patches (lichen planus), submucous fibrosis, etc. Early identification and monitoring of these potentially cancerous lesions allow clinicians to detect and treat the early stages of oral cancers.
Apart from encouraging the self-examination of mouth for any abnormal patches and regular check-ups, the following methods may be used by the doctor to screen for oral cancers:
- The oral brush biopsy (OralCDx Brush Test system) is a method to collect a cell sample from the abnormal areas. A specially designed brush is used to collect cells, which are fixed and stained on a glass slide. These are then analyzed microscopically via a computer-based imaging system. Results are reported as "positive," "atypical," or “negative.” The abnormal reports (positive or atypical) need a biopsy to confirm cancer. The available evidence states that this test is highly sensitive and specific in detecting pre-cancerous changes in high-risk patients.
- Exfoliative cytology is a procedure to collect cells from the lip or oral cavity where a piece of cotton or small wooden stick is used to gently scrape cells from the abnormal areas of the lips, tongue, mouth, or throat. The cells are viewed under a microscope to find out if they are abnormal.
- Toluidine blue stain is a procedure in which the abnormal areas in the mouth are coated with a blue dye. The areas that stain darker are more likely to be cancerous or develop cancer.
- The ViziLite system by Zila Pharmaceuticals involves rinsing the mouth with a 1% acetic acid solution for 1 minute followed by the examination of the oral lining under a special light. The acetic acid slightly dehydrates the oral lining. The abnormal oral cells absorb and reflect the light in a different manner. The normal cells appear blue, whereas abnormal areas appear whiter with sharper margins.
- Tissue autofluorescence technique has been developed by LED Medical Diagnostics Incorporation in partnership with the British Columbia Cancer Agency and is marketed as the VELscope system. It is used to scan the abnormal cells inside the mouth. The normal oral mucosa emits a pale green autofluorescence when viewed through the handpiece instrument. The abnormal cells appear darker.
- Tissue fluorescence spectroscope system consists of a small optical fiber that produces various wavelengths of light. A graph records the reflected fluorescence from the tissue. Depending on whether the tissue is healthy or abnormal, the wavelength varies. The reports are generated by computer accordingly.
Health Solutions From Our Sponsors
World Health Organization. Screening for Oral Cancer. https://www.who.int/cancer/detection/oralcancer/en/
Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. January 30, 2009;1:5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654034/
Top How do you screen for oral cancer? Related Articles
artificial salivaArtificial saliva is used as a saliva substitute to relieve the symptoms of dry mouth (xerostomia) when natural saliva production is deficient or absent due to certain conditions. Artificial saliva is also used to alleviate oral inflammation (mucositis) from chemotherapy or radiotherapy treatments for cancer. Common side effects of artificial saliva include taste perversion (dysgeusia), swallowing difficulties (dysphagia), minor gastrointestinal problems, and speech disturbance. Artificial saliva has no listed drug interactions. Consult your doctor if pregnant or breastfeeding.
CancerCancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
fluorideFluoride, or sodium fluoride, is an inorganic chemical compound used to prevent dental caries and maintain dental health. Common side effects of fluoride include skin rash, hypersensitivity reaction, nausea, vomiting, and temporary dental discoloration (with products containing stannous fluoride). Take fluoride supplementation exactly as prescribed. Do not take fluoride supplements if there is adequate intake from fluorinated drinking water.
Painful Teeth ConditionsGot aching teeth? Your pain may be coming from somewhere other than your choppers.
What Do Early Signs of Tongue Cancer Look Like?Tongue cancer is a serious form of oral cancer. In most patients, there may be a few to no symptoms in the early stages of tongue cancer.
What Is the Survival Rate of Salivary Gland Cancer?The survival rate of salivary gland cancer depends on several factors. The overall five-year survival rate for salivary gland cancer in the United States is 75 percent. The survival rate depends on the type and stage of the salivary gland cancer. The five-year survival rate for people with early-stage (localized) salivary gland cancer is 94 percent. The five-year survival rate for people with salivary gland cancer that spreads to nearby structures and lymph nodes is 67 percent. The five-year survival rate for people with advanced-stage (metastatic) cancer is 44 percent.